Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Biogen 2.736, Becton Dickinson 4.983.
Biogen vs Becton Dickinson: Revenue Comparison
Biogen (BIIB) and Becton Dickinson (BDX) are peers in Healthcare. Biogen reported revenue of $2.7B as of Q2 2026, compared with $5.0B for Becton Dickinson. Becton Dickinson leads on revenue.
Biogen's gross margin is 56.9% versus 46.5% for Becton Dickinson. Biogen's net margin is 3.6% versus 7.6% for Becton Dickinson.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Biogen, Becton Dickinson.| Metric | Biogen | Becton Dickinson |
|---|---|---|
| Market Cap | - | - |
| Revenue | $2.74B | $4.98B |
| Cost of Revenue | $1.18B | $2.67B |
| Gross Profit | $1.56B | $2.31B |
| Operating Income | $318.00M | $663.00M |
| Net Income | $98.00M | $377.00M |
| R&D Expense | $496.00M | $258.00M |
| Earnings Per Share | $0.66 | $1.37 |
| Gross Margin | 56.9% | 46.5% |
| Operating Margin | 11.6% | 13.3% |
| Net Profit Margin | 3.6% | 7.6% |
| Free Cash Flow | $490.00M | $509.00M |
| Cumulative Free Cash Flow | $47.88B | $39.60B |
| Operating Cash Flow | $449.00M | $652.00M |
| Cash & Equivalents | $1.28B | $708.00M |